Allstate reports Wednesday after the close with short interest climbing steadily through April and options positioning showing little conviction either way. The property and casualty insurer closed Friday at $212.88, down 1.5% on the week but still up 2.7% over the past month. Short sellers have added to their bets in recent weeks — shares short rose 12% over the past month to 7.0 million, representing 2.7% of the float. The move pushed days to cover to 5.7, near the higher end of its recent range. Borrow costs remain negligible at 0.45%, up modestly from a month ago but still reflecting ample supply. Utilisation sits at 3.1%, well off the 52-week high of 3.7% hit earlier this year.
Options sentiment is flat. The put/call ratio closed at 1.09 on Thursday, running slightly below its 20-day mean of 1.10. The z-score is -0.15 — essentially neutral. Over the past year the PCR has ranged from 0.66 to 1.31, and the current reading sits squarely in the middle. Bulls point to accelerating growth in the personal auto book, where policies in force rose 1.3% and momentum picked up to 2.8% monthly growth in the most recent quarter. The company beat estimates in February on strong underlying underwriting and favorable loss reserve development in auto, even as the combined ratio ran worse than the long-term 95% target at 89.4%. Normalization in loss costs and stable pricing set up the potential for margin expansion if competitive pressures remain contained. Bears counter that the year-to-date combined ratio signals ongoing inefficiencies, and personal lines face both pricing pressure and the risk of a downturn if competition intensifies. A sharp capital markets correction would hit the investment portfolio hard, and catastrophic losses beyond reinsurance limits remain a tail risk. Analyst activity has been cautious. Mizuho cut its target from $281 to $265 in late March while keeping an Outperform rating — a signal that even bulls are trimming estimates. Wells Fargo and Barclays each nudged targets higher in early April but kept neutral-to-negative ratings. The mean price target of $240 implies 13% upside from here, though the Street is split between Overweight and Underweight calls.
Institutional holders have been net buyers. State Street added 438,000 shares in the March quarter, Putnam added 1.1 million, and GQG Partners lifted its stake by 1.5 million shares in late February. Insiders sold roughly $14.9 million net over the past 90 days, led by CEO Tom Wilson, who offloaded shares in two separate March transactions. The sales carry low significance scores and likely reflect routine equity compensation management rather than a fundamental view. Historical earnings reactions have been volatile. After the February print the stock jumped 6.7% the next day, though it gave back most of that move over the following week. The prior three events saw an average five-day decline of roughly 4%. Peers in the property and casualty space have underperformed — HIG fell 3.9% on the week, PGR dropped 0.8%, and THG lost 2.4%. Allstate's relative outperformance suggests the market is waiting for the company to prove it can sustain auto momentum without sacrificing profitability.
The earnings call will test whether growth is accelerating without eroding the combined ratio, and whether management can articulate a path back to the 95% target while defending against pricing competition.
See the live data behind this article on ORTEX.
Open ALL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
